• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Guardion Health Sciences, Inc. (GHSI) Stock Price, News & Analysis

Guardion Health Sciences, Inc. (GHSI) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$3.22
Day's range
$3.22
50-day range
$3.04
Day's range
$11.34
  • Country: US
  • ISIN: US40145Q5009
52 wk range
$3.04
Day's range
$18
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -5.54
  • Piotroski Score 5.00
  • Grade Buy
  • Symbol (GHSI)
  • Company Guardion Health Sciences, Inc.
  • Price $3.22
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $3.22
  • Day High $3.22
  • Year High $18.00

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

  • Last Earnings 08/21/2024
  • Ex-Dividend for 5/16 Dividend 09/24/2024
  • Dividend Payable N/A
  • Today N/A
  • Next Earnings (Estimated) 11/10/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.01
  • High Stock Price Target $0.01
  • Low Stock Price Target $0.01
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$4.01
  • Trailing P/E Ratio -2.47
  • Forward P/E Ratio -2.47
  • P/E Growth -2.47
  • Net Income $158,033

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Guardion Health Sciences, Inc. Frequently Asked Questions

  • What is the Guardion Health Sciences, Inc. stock price today?

    Today's price of Guardion Health Sciences, Inc. is $3.22 — it has decreased by 0% in the past 24 hours. Watch Guardion Health Sciences, Inc. stock price performance more closely on the chart.

  • Does Guardion Health Sciences, Inc. release reports?

    Yes, you can track Guardion Health Sciences, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Guardion Health Sciences, Inc. stock forecast?

    Watch the Guardion Health Sciences, Inc. chart and read a more detailed Guardion Health Sciences, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Guardion Health Sciences, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Guardion Health Sciences, Inc. stock ticker.

  • How to buy Guardion Health Sciences, Inc. stocks?

    Like other stocks, GHSI shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Guardion Health Sciences, Inc.'s EBITDA?

    Guardion Health Sciences, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Guardion Health Sciences, Inc.’s financial statements.

  • What is the Guardion Health Sciences, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.0129021803, which equates to approximately 1.29%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Guardion Health Sciences, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Guardion Health Sciences, Inc.'s financials relevant news, and technical analysis. Guardion Health Sciences, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Guardion Health Sciences, Inc. stock currently indicates a “sell” signal. For more insights, review Guardion Health Sciences, Inc.’s technical analysis.

  • A revenue figure for Guardion Health Sciences, Inc. for its last quarter?

    Guardion Health Sciences, Inc. published it's last quarterly revenues at $72,918.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.